Christopher Wynne - Concepedia

Author

Christopher Wynne

Also Known As

A.G. Soetaert, C J WYNNE, C Wynne, C. J. WYNNE, C. Wynne, C.J Wynne, C.J. Wynne, CHRISTOPHER J. WYNNE, Christopher J Wynne, Christopher J. Wynne

Publications

994

Citations

H-Index

Concepts

All Affiliations

Christchurch Clinical Studies Trust National University Hospital Christchurch Hospital Boehringer Ingelheim (Germany)Alvotech (Germany)

About

Christopher Wynne is an author at Christchurch Clinical Studies Trust specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	533
2	Health Sciences	4	4	178
3	Nursing	2	2	27
4	Allergy	1	1	27
5	Anesthesia	1	1	45

Christopher Wynne

Publications

884

Citations

H-Index

Page 1

	Year	Citations
The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial Anders Bonde Jensen, Christopher Wynne, Guillermo Ramírez, Clinical Breast Cancer Bone DiseaseBreast OncologyMedicinePathologyBreast Cancer	2010	143
Merkel cell tumor. A chemosensitive skin cancer Christopher Wynne, John H. Kearsley Cancer	1988	88
Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial Elaine Beller, Martin Tattersall, Thomas Lumley, Annals of Oncology Megestrol AcetateEndocrine OncologyOncologyHealth SciencesMedicine	1997	83
Controversies in the management of laryngeal cancer: results of an international survey of patterns of care Brian O'Sullivan, William J. Mackillop, Ralph Gilbert, Radiotherapy and Oncology Surgical OncologyMedicineLaryngectomyOutcomes ResearchLaryngeal Cancer	1994	77
Cultural attitudes to cancer management in traditional South‐East Asian patients Keith Ong, Michael Back, Jiade J. Lu, Australasian Radiology	2002	72
Patient Preference for Radiotherapy Fractionation Schedule in the Palliation of Painful Bone Metastases Thomas P. Shakespeare, Jiade J. Lu, Michael Back, Journal of Clinical Oncology	2003	68
Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects Christopher Wynne, Mario Altendorfer, Ivo Sonderegger, Expert Opinion on Investigational Drugs	2016	59
A Study of Complications Arising From Different Methods of Anesthesia Used in High-Dose-Rate Brachytherapy for Cervical Cancer Keith Lim, Jiade J. Lu, Christopher Wynne, American Journal of Clinical Oncology Hdr BrachytherapyPain MedicineSurgeryGynecology Oncology3-Channel Hdr Brachytherapy	2004	45
Treatment and planning decisions in non-small cell carcinoma of the lung: An Australasian patterns of practice study C.S. Hamilton, James W. Denham, David Joseph, Clinical Oncology OncologyPractice StudyCancer ManagementAustralasian PatternsOutcomes Research	1992	34
Efficacy of an integrated continuing medical education (CME) and quality improvement (QI) program on radiation oncologist (RO) clinical practice Cheng Nang Leong, Thomas P. Shakespeare, Rahul Mukherjee, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyMedicineRadiation OncologistRadiologic Education	2006	29

Page 1